|
|
|
|
Pfizer European R&D Headquarters, Sandwich, Kent
Pfizer's Sandwich site is the company's European R&D headquarters and the global manufacturing hub.Located in south-east Kent, UK, the site began research activities in 1957 with a small team of six scientists. Over the years it has expanded to an...
|
|
|
Vetter Accela Form - Five keys to reducing time-to-market
_ Vetter Accela Form - Five keys to reducing time-to-market.
|
|
|
Optimising Quality and Production in the Pharmaceutical and Dietary Supplement Industries
Raising the bar in the dietary supplement industry to pharmaceutical standards, Enzymatic Therapy has relied on compact vibratory screeners to optimise product quality and production while meeting growing demand.When Enzymatic Therapy stopped outsourcing and...
|
|
|
GlaxoSmithKline Increases Process Efficiency with Russell Finex's Vibrasonic Deblinding System
GlaxoSmithKline Increases Process Efficiency with 's Vibrasonic Deblinding System Press Release GlaxoSmithKline Increases Process Efficiency with 's Vibrasonic Deblinding System   19 March 2010 GlaxoSmithKline is improving process efficiency in the...
|
|
|
Sieving for Safety with Russell Finex
Sieves or screeners are an essential part of every pharmaceutical production process, particularly as product quality and integrity are so important.The use of sieves safeguards against customer compensation or litigation, as it eliminates all oversized...
|
|
|
New Drug Approved for High Blood Ammonia Levels
The US Food and Drug Administration (FDA) has approved Carbaglu (carglumic acid) to treat a extremely rare genetic disorder that results in too much ammonia in the blood.The condition, N-acetylglutamate synthase or NAGS deficiency, is an extremely rare...
|
|
|
Ipsen Initiates Two Studies to Evaluate Carcinoid Drug
Ipsen has initiated two Phase II clinical studies to evaluate the efficacy and safety of BIM 23A760, a new drug to treat patients suffering from carcinoid syndrome due to neuroendocrine tumours.Acromegaly is a rare disorder caused by the over-production of...
|
|
|
Physiomics Simulations to Boost Cancer Drug Development
UK firm Physiomics has signed an agreement with Sareum, The Institute of Cancer Research and Cancer Research Technology to provide silico simulations to support cancer drug development.Physiomics will extend its modelling expertise in biological processes to...
|
|
|
OriGene to Build Largest Monoclonal Antibody Collection
OriGene Technologies has raised $16m to build what is described as the largest collection of next-generation monoclonal antibodies, which will cover the majority of the human proteome.The funding will be used to continue to build OriGene's TrueMAB monoclonal...
|
|
|
Shimadzu's TOC-V series
covers all water quality analysis requirements.Two systems within this series are particularly suitable for TOC analysis in pharmaceutical applications. Both offer a wide measuring range of 0.5 g/L up to 25.000 mg/L and support a broad variety of...
|
